Navigation Links
ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting
Date:3/12/2009

PHILADELPHIA, March 12 /PRNewswire/ -- ERT, a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, announced today that it will be showcasing its portfolio of products and services on Booth #1253/1254 at the 21st Annual DIA Euromeeting, 23-25 March 2009 in Berlin, Germany. ERT is also inviting attendees to three speaking sessions, which will discuss the impact of technology and standards on drug delivery.

Following a successful company rebranding exercise, ERT has unveiled four new sub-brands of its industry-leading products and services, including ERT Cardiac Safety Solutions, ERT EDC Solutions, ERT ePRO Solutions, and ERT Clinical Research Consulting Group. ERT representatives will be on booth at the DIA Euromeeting to discuss the Company's latest innovations, as well as the latest advancements within the industry.

In addition, ERT will be taking part in three presentations at the Euromeeting under the conference track, The Impact of Technology and Standards on Drug Development: Now Better, Safer and Faster. The first talk, entitled "The Loose Ends in EDC and How to Address Them," will be held on 24 March between 4:00 pm - 5:30 pm. The second session - "A Look into the Future: What is on the Horizon After We Have Managed EDC Properly?" - will be held from 9:00 am to 10:30 am, on 25 March. The final session will also be held on 25 March between 2:00 pm - 3:30 pm entitled "CDISC end-to-end: To What Extent Do the CDISC Standards Achieve Information System Independence?"

DIA's 21st Annual Euromeeting attracts more than 3,000 professionals from over 50 countries. It brings together representatives from the biopharmaceutical industry, contract service organizations, academic research centers, regulatory agencies, health ministries, patients' organizations and trade associations. More than 240 exhibitors will be taking part at the DIA meeting, which will also feature more than 125 sessions and 21 preconference tutorials focusing on issues affecting global drug discovery and development.

ERT is a leading provider of technology and services to the biopharmaceutical and medical device industries around the world. The four key areas of ERT products and services are all enabled by the Company's innovative technology platform - EXPERT(TM). EXPERT(TM) is a robust, secure, and validated clinical-research workflow-processing system that powers centralized electronic data collection, data management, and information exchange.

For further information about ERT's clinical trial solutions please visit Booth #1253/1254 at DIA 21st Annual Euromeeting in Berlin. Alternatively, please email info@ert.com, call +1 866 538 2808 or visit www.ert.com.

About ERT

Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (www.ert.com) is a provider of technology and services to the biopharmaceutical and medical device industries on a global basis. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2009 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
2. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
3. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
4. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
5. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
6. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
7. CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line
8. Tasker Products to Showcase Tasker Blue at International Poultry Expo
9. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
10. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
11. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... representations of a complex biological network, a depiction of a system of linkages ... said Dmitry Korkin, PhD, associate professor of computer science at Worcester Polytechnic Institute ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, will ... analytical testing are being attributed to new regulatory requirements for all new drug ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
Breaking Biology Technology:
(Date:10/4/2017)... 4, 2017  GCE Solutions, a global clinical research organization (CRO), ... anonymization solution on October 4, 2017. Shadow is designed to assist ... with policy 0070 of the European Medicines Agency (EMA) in meeting ... ... ...
(Date:6/30/2017)... Today, American Trucking Associations announced Seeing ... and eye tracking software, became the newest member ... "Artificial intelligence and advanced sensing algorithms ... driver,s attentiveness levels while on the road.  Drivers ... fatigue and prevent potential accidents, which could lead ...
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
Breaking Biology News(10 mins):